The aim of the study was to investigate the impact of various blood pressure (BP) measurement methods on the assessment of differences in BP levels between patients with normoalbuminuric type 1 diabetes and healthy controls. We measured intra-arterial BP (i.a.), sphygmomanometric BP (sphygmo), 24-h ambulatory blood pressure (ABPM, auscultatory, Profilomat 
Introduction
The standard measurement of office blood pressure (BP) is still mostly done with a mercury sphygmomanometer but is increasingly replaced by new methods using auscultatory or oscillometric (semi-) automatic devices. In patients with type 1 diabetes mellitus adequate control of BP is of utmost importance in order to minimise cardiovascular and renal morbidity and mortality. [1] [2] [3] [4] [5] Furthermore, it is unclear if in patients with type 1 diabetes an increase in BP precedes or follows the onset of microalbuminuria. 4, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] It is clear that accurate measurements of BP are of great importance. In the various studies mentioned before, the methods of BP 
05). Diastolic Dinamap
® BP was not significantly different (66.6 ± 0.7 in DP vs 65.0 ± 1.0 mm Hg in C). We conclude that intra-arterial BP was similar in patients with normoalbuminuric type 1 diabetes and healthy controls. Also, when using auscultatory BP devices there were no apparent differences in blood pressure. In contrast, using the oscillometric method (Dinamap ® ), BP especially systolic, was higher in diabetic patients. Measurements with an oscillometric device (Dinamap ® ) might therefore overestimate BP in patients with normoalbuminuric type 1 diabetes, thus confusing conclusions on the relationship between development of hypertension and microalbuminuria in the early phase of diabetes. measurement are not the same. It has been demonstrated that oscillometric devices and the sphygmomanometer are not interchangeable, at least in clinical practice. 19 Therefore, in the present study we have measured intra-arterial BP, mercury sphygmomanometer BP, 24-h ambulatory BP (ABPM, Profilomat ® , auscultatory) and BP with an oscillometric device (Dinamap ® ) in 51 normoalbuminuric type 1 diabetic patients and 42 healthy controls.
Patients and methods

Study population
The study was performed in 51 patients with normoalbuminuric type 1 diabetes mellitus and 42 healthy control subjects. Informed consent was obtained from all participants and the study was approved by the local ethics committee. The diabetic patients were eligible for the study when the following criteria were fulfilled: duration of diabetes between 5-12 years, age between 18-40 years, BP Ͻ140/90 mm Hg (mercury sphygmomanometer; subjects with differences in BP between the left and right arm of more than 10 mm Hg were excluded), no antihypertensive medication, no clinical evidence of macrovascular disease and no signs of microvascular complications such as microalbuminuria or retinopathy (except for simple background retinopathy). Albuminuria was assessed in two timed overnight urine samples. Persistent normoalbuminuria was defined as an albumin excretion rate Ͻ20 g/min. The diabetic patients were regularly attending the diabetic out-patient clinic. Healthy controls were recruited from the local Caucasian population. Before inclusion in the study these volunteers were screened for the absence of hypertension (BP Ͼ140/90 mm Hg) or a difference in BP between the left and right arm of more than 10 mm Hg, cardiovascular disease, renal dysfunction and proteinuria. Medication was not allowed except for oral contraceptives in females. All subjects were on an ad libitum sodium diet. Before the study, 24-h urinary sodium excretion was measured, as a measure of mean sodium intake.
Study protocol
Except for the ABPM, all studies were performed between 08.00 and 10.00 am, in a temperature controlled room (23°C). The observer (GV) and the equipment used were the same throughout the whole study. Not all BP measurements were performed simultaneously but the order as well as time of measurements were exactly the same in both groups.
(1) Intra-arterial BPs were measured for at least 5 min (Ͼ300 heart beats) minimally 45 min after cannulation of the left brachial artery in the supine position. The brachial artery was cannulated with a 20-gauge Angiocath (Deseret Medical, Becton Dickinson, Sandy, UT, USA) under local anaesthesia (2% xylocaine) for BP and heart rate (HR) monitoring (Baxter Pressure Monitoring Kit, Bentley Laboratories Europe, Uden, The Netherlands and Hewlett Packard GmbH, Bö blingen, Germany).
(2) Sphygmomanometer BP (Erkameter 300 ® , cuff size 13 × 36 cm) was measured at the right arm after 10 min of supine rest. Three measurements were performed each 1 min apart. Korotkoff I and V sounds (nearest 2 mm Hg) were taken as systolic and diastolic BP respectively.
(3) ABPM was performed with a Profilomat ® system (Disetronic Medical Systems AG, Burgdorf, Switzerland) for 24 h on a normal working day at the non-dominant arm to find out whether there could be differences in BP with respect to the time of measurement. The Profilomat ® is an automatic ambulatory, portable BP monitor which permits auscultatory (by Riva-Rocci/Korotkoff) recording and storage of BP readings over a period of 24 h. The raw data were manually checked and inappropriate readings removed. 20 The Profilomat ® has been recommended for measurement of ABPM in clinical practice achieving a 'B' for systolic and an 'A' for diastolic BP according to the British Hypertension Society. 21 BP readings between 10.00 and 23.00 h were averaged as 'daytime' BP and between 01.00 and 07.00 as 'night-time' BP since this is a good estimation of BP during waking and sleeping periods respectively.
(4) Blood pressure measurements by Dinamap
® (type 1846 SX , Critikon, Tampa, FL, USA) were performed during 20 min on a separate occasion at 1-min intervals in the supine position at the left arm. The Dinamap ® monitor is a microprocessor controlled non-invasive device that automatically measures mean arterial pressure (MAP) at the moment of maximal oscillation and then calculates systolic and diastolic BP using an unknown algorithm. BP recordings of the last 10 min, when BP was stabilised, were averaged (10 readings).
Statistical analysis and data report
Values are given as means ± SE or 95% confidence intervals (CI) unless otherwise indicated. Statistical analysis was performed by Student's t-test for normally distributed data and Mann-Whitney U test for non-parametric data. Only differences between groups were tested and not within groups, since BP measurements were not all performed simultaneously. Differences were considered statistically significant at P Ͻ 0.05. Table 1 summarises the characteristics of the diabetic patients (DP) and the control subjects (C). There were no demographic differences between the groups. One normotensive patient with diabetes was excluded because of the use of angiotensin-converting enzyme (ACE)-inhibition and one healthy control was excluded because of a BP difference of 20 mm Hg between left and right arm. There were no subjects excluded because of hypertension (BP Ͼ 140/90 mm Hg) at inclusion. Intra-arterial BP was not significantly different between both groups (Table 2) . Systolic i.a. BP ranged from 102-137 mm Hg in DP and from 95-138 mm Hg in C. Diastolic i.a. BP ranged from 49-76 mm Hg in DP and from 53-79 mm Hg in C, Values are expressed as means ± SE. AER, albumin excretion rate whereas MAP ranged respectively from 72-100 mm Hg in DP vs 71-104 mm Hg in C. HR was 66.5 ± 1.4 bpm in DP vs 62.5 ± 1.6 in C (NS). When BPs were also measured with the sphygmomanometer no significant differences between the insulin-dependent diabetes mellitus (IDDM) patients and the controls were noted (Table 2) .
Results
Also, 24-h BP profiles measured with an auscultatory device (Profilomat ® ) were quite similar (Table 2, Figure 1 ). Mean systolic day-night difference was 18.3 mm Hg (95% CI 16.3 to 20.3) in DP and 17.4 mm Hg (95% CI 14.1 to 20.6) in C (NS). The diastolic day-night difference was also not significantly different (15.3 mm Hg (95% CI 13.6 to 16.9) in DP and 14.9 mm Hg (95% CI 12.3 to 17.5) in C, NS). Mean HR during the day was 81.7 ± 1.5 bpm in DP and 77.9 ± 1.4 in C, whereas night-time HR was 63.6 ± 1.4 in DP and 64.0 ± 1.5 in C (NS).
In contrast, measurements of BP with the oscillometric device (Dinamap ® ) suggested a difference in both systolic and mean arterial pressure between IDDM patients and the control subjects (Table 2) . Oscillometric BP monitoring showed a significantly higher systolic BP in diabetic patients (118.6 ± 1.3 mm Hg in DP vs 113.4 ± 1.4 in C, P = 0.01 ( Figure   Figure 1 Hourly means (± SE) of 24-h ambulatory blood pressure monitoring (Profilomat ® , auscultatory) in healthy controls (-˿-) and type 1 diabetic patients (--).
2)). MAP was also significantly higher in normoalbuminuric diabetic patients (85.6 ± 0.7 vs 83.3 ± 1.0 mm Hg in C, P = 0.05). Diastolic BP was not significantly different (66.6 ± 0.7 mm Hg in DP vs 65.0 ± 1.0 in C).
Discussion
In this study we have assessed differences in BP between patients with normoalbuminuric type 1 diabetes and healthy controls using various BP measurements methods. Since BP measurements were not all performed simultaneously a quantitative comparison between the BP measurements methods within each group is not justified.
Our study indicates that intra-arterial BP is not increased in patients with normoalbuminuric type 1 diabetes mellitus and a diabetes duration of 5-12 years. Similar results were obtained when using auscultatory techniques, eg, the mercury sphygmomanometer and the Profilomat ® . However, when using an oscillometric device (Dinamap ® ), BPs were apparently higher in the diabetic patients. We must conclude that the oscillometric device probably overestimates BPs in normoalbuminuric type 1 dia-
Figure 2 Dinamap
® blood pressures (BP, mm Hg, mean ± SE at 1-min intervals during 20 min in supine position in healthy controls (-२-) and type 1 diabetic patients (--).
betic patients since the intra-arterial BP measurement is regarded as the 'gold standard' for these measurements.
It is still a matter of debate whether BP is increased in patients with normoalbuminuric type 1 diabetes. Contrasting results have been reported regarding the prevalence of hypertension in patients with normoalbuminuric IDDM, showing either a slightly higher than expected or a normal percentage of IDDM patients with elevated BP. [7] [8] [9] [10] [11] [12] Some investigators have reported that even in young diabetic patients BP is increased, 9,10 but others did not find a difference in systolic BP between diabetic children and a reference population whereas diastolic BP tended to be even lower. 11 Although most cross-sectional as well as longitudinal studies on the prevalence of elevated BP in type 1 diabetes suggest an association between microalbuminuria and BP rise, it is still controversial whether the increase of arterial BP precedes, follows or develops in parallel with the onset of microalbuminuria. [2] [3] [4] [5] [6] [13] [14] [15] [16] 23, 24 These discrepancies on the prevalence of increased BP in type 1 diabetic patients at the onset of microalbuminuria can be attributed, at least partially, to differences in the study populations with respect to factors as age, diabetes duration, gender, sodiumintake, presence of autonomic neuropathy, the number of smokers vs non-smokers and urinary albumin excretion. However, from our data it is evident that differences in techniques of BP measurements should also be taken into account.
Therefore, we decided to take a closer look at the literature on BP in type 1 diabetes mellitus with emphasis on the specific technique to measure BP. To our knowledge, there are no studies reporting intra-arterial BP in normoalbuminuric type 1 diabetic patients.
Many investigators have measured office BP using the mercury sphygmomanometer, especially the random zero sphygmomanometer. In all but one study no difference in BP was observed between healthy controls and patients with normoalbuminuric type 1 diabetes, when adjusting for albuminuria, diabetes duration, age and gender. 3, 4, 11, 12, 14, 16, [25] [26] [27] We have used an automatic auscultatory device (Profilomat ® ) to measure 24-h BPs and found no significant difference in 'daytime' or 'night-time' BP or in systolic or diastolic day-night differences between diabetic patients and controls. These results are somewhat in contrast with data from studies in which 24-h BPs were measured with an oscillometric device. Although not found by all, most of these studies report an increased (mainly systolic) BP especially during the night or a decrease in systolic and diastolic day-night differences in patients with normoalbuminuric type 1 diabetes (Table 3) . 14, 16, [25] [26] [27] [28] [29] [30] [31] We are only aware of two reports in which auscultatory devices were used for measuring 24 h BPs. In both studies no difference in 24-h ambulatory BPs between patients with normoalbuminuric type 1 diabetes and healthy controls was found. 17, 18 Altogether, these findings are compatible with our data showing an overestimation of BP by the oscillometric device (Dinamap ® ) in type 1 diabetic patients. It has been suggested that this oscillometric device may overestimate BP in diabetic patients, especially at normal BP range. 32 It could be questioned whether this BP overestimation is common to all oscillometric methods or is limited to the specific algorithm used in the Dinamap ® device. However, recently it was shown that the overestimation of systolic BP was more severe in normoalbuminuric type 1 diabetic patients compared to healthy controls, when using SpaceLabs and a sphygmomanometer. 33, 34 Therefore, we conclude that the overestimation of BP in patients with normoalbuminuric type 1 diabetes is most probably inherent to oscillometry and not to device specific algorithms. In the latter study diastolic BP was also higher in diabetic patients. Diabetes duration most likely explains the difference between this study and ours. Disease duration was an important determinant of the limits of agreement between the oscillometric device and the sphygmomanometer. Diabetes duration ranged from 0.25-51 years, whereas in our study diabetes duration was between 5 and 12 years.
We have no explanation why oscillometric devices overestimate BP in patients with normo- albuminuric diabetes mellitus. The device used in our study measures BP by oscillometric means; a stepped deflation sequence is started determining arterial BP and pulse rate from pulses induced in the cuff at the varied pressure levels. A sensitive transducer not only measures cuff pressure, but also minute pressure oscillations within the cuff. It could be hypothesised that changes in the elastic properties of the arterial wall contribute to alterations in oscillations. Admittedly, there were no signs of microangiopathy in our diabetic patients. However, abnormalities of vessel wall, particularly the lower extremities in normoalbuminuric diabetic patients have been demonstrated. 35 Furthermore, in patients with normoalbuminuric type 1 diabetes basal (capillary) blood flow is increased, 36 and such increases in blood flow influence arterial wall (shear) stress and might influence oscillometric behaviour. 37 In future studies, alterations in vessel wall properties in relation to BP and diabetes duration should be addressed by using 2D Doppler techniques.
We conclude that there is no difference in BP between patients with normoalbuminuric type 1 diabetes and a diabetes duration between 5-12 years, and healthy control subjects when i.a BP is used as 'gold standard'. When using the auscultatory devices, the mercury sphygmomanometer and ABPM (Profilomat ® ), also no differences in BP between both groups were noted. In contrast, the oscillometric device (Dinamap ® ) showed a substantial difference in BP between patients with normoalbuminuric type 1 diabetes and C. With this device in particular systolic BP and MAP are overestimated in type 1 diabetes mellitus. Evidently, there is a need for prospective studies to elucidate the relation between different BP measurement methods and end-organ damage eg, micro-angiopathy in patients with diabetes mellitus. So far, when BP values are studied in normoalbuminuric type 1 diabetic patients, oscillometric methods should be interpreted with caution and compared with conventional methods of BP recording.
